Brown, Lisle/Cummings’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Buy |
69,606
+7,101
| +11% | +$172K | 0.45% | 55 |
|
|
2025
Q1 | $1.58M | Buy |
62,505
+1,197
| +2% | +$30.3K | 0.46% | 54 |
|
|
2024
Q4 | $1.63M | Buy |
61,308
+3,824
| +7% | +$101K | 0.49% | 54 |
|
|
2024
Q3 | $1.66M | Buy |
57,484
+158
| +0.3% | +$4.57K | 0.51% | 51 |
|
|
2024
Q2 | $1.6M | Buy |
57,326
+2,263
| +4% | +$63.3K | 0.52% | 48 |
|
|
2024
Q1 | $1.53M | Buy |
55,063
+4,843
| +10% | +$134K | 0.52% | 47 |
|
|
2023
Q4 | $1.45M | Buy |
50,220
+15,990
| +47% | +$460K | 0.54% | 47 |
|
|
2023
Q3 | $1.14M | Buy |
34,230
+7,927
| +30% | +$263K | 0.51% | 49 |
|
|
2023
Q2 | $965K | Buy |
26,303
+4,879
| +23% | +$179K | 0.43% | 57 |
|
|
2023
Q1 | $874K | Buy |
21,424
+1,457
| +7% | +$59.4K | 0.44% | 54 |
|
|
2022
Q4 | $1.02M | Buy |
19,967
+1,749
| +10% | +$89.6K | 0.55% | 48 |
|
|
2022
Q3 | $797K | Buy |
18,218
+2,730
| +18% | +$119K | 0.47% | 53 |
|
|
2022
Q2 | $812K | Sell |
15,488
-432
| -3% | -$22.6K | 0.45% | 58 |
|
|
2022
Q1 | $824K | Sell |
15,920
-432
| -3% | -$22.4K | 0.4% | 62 |
|
|
2021
Q4 | $966K | Buy |
+16,352
| New | +$966K | 0.48% | 52 |
|